Abstract
Treatment concepts for premature ovarian failure concern restoration, preservation, and substitution of ovarian function. To date, there is no effective treatment to restore ovarian function. Preservation of ovarian function using cryopreservation and auto- or xenotransplantation will be possible in the near future. Regulation of the dynamics of the oocyte pool through GDF9 or AMU is not envisaged in the near future. Developments in estrogen receptor research may change treatment concepts in hormone replacement therapy.
Article PDF
Avoid common mistakes on your manuscript.
References
van Kasteren YM, Hoek A, Schoemaker J. Ovulation induction in premature ovarian failure: A placebo-controlled randomized trial combining pituitary suppression with gonadotropin stimulation. Fertil Steril 1995;64:273–8.
Taylor AE, Adams JM, Mulder JE, Martin KA, Sluss PM, Crowley WF. A randomized, controlled trial of oestradiol replacement therapy in women with hypergonadotropic amenorrhoea. J Clin Endocrinol Metab 1996;81:3615–21.
Surrey ES, Cedars MI. The effect of gonadotropin suppression on the induction of ovulation in premature ovarian failure patients. Fertil Steril 1989;52:36–41.
Nelson LM, Kimzey LM, White BJ, Merriam GR. Gonadotropin suppression for the treatment of karyotypically normal spontaneous premature ovarian failure: A controlled trial. Fertil Steril 1992;57:50–5.
Rosen GF, Stone SC, Yee B. Ovulation induction in women with premature ovarian failure: A prospective, crossover study. Fertil Steril 1992;57:448–9.
Anasti JN, Kimzey LM, Defensor RA, White B, Nelson LM. A controlled study for the treatment of karyotypically normal spontaneous premature ovarian failure. Fertil Steril 1994;62:726–30.
van Kasteren YM, Braat DDM, Hemrika DJ, et al. Corticosteroids do not influence ovarian responsiveness to gonadotropins premature ovarian failure (POF): A randomized, placebo-controlled trial. Fertil Steril 1999;71;90–5.
van Kasteren YM, Schoemaker J. Premature ovarian failure: A systematic review on therapeutic interventions to restore ovarian function and achieve pregnancy. Hum Reprod Update 1999;5:483–92.
Durlinger AL, Kramer P, Karels B, et al. Control of primordial follicle recruitment by anti-Mullerian hormone in the mouse ovary. Endocrinology 1999;140:5789–96.
Oktay K, Newton H, Gosden RG. Transplantation of cryopreserved human ovarian tissue results in follicle growth initiation in SCID mice. Fertil Steril 2000;73:599–603.
Oktay K, Karlikay G. Ovarian function after transplantation of frozen, banked autologous ovarian tissue. N Engl J Med 2000;342:1919.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
This article is published under an open access license. Please check the 'Copyright Information' section either on this page or in the PDF for details of this license and what re-use is permitted. If your intended use exceeds what is permitted by the license or if you are unable to locate the licence and re-use information, please contact the Rights and Permissions team.
About this article
Cite this article
van Kasteren, Y. Treatment Concepts for Premature Ovarian Failure. Reprod. Sci. 8 (Suppl 1), S58–S59 (2001). https://doi.org/10.1177/1071557601008001S18
Published:
Issue Date:
DOI: https://doi.org/10.1177/1071557601008001S18